CYCLERION THERAPEUTICS INC (CYCN)

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Cyclerion is leveraging its legacy sGC stimulator assets to generate near-term revenues which will be used to implement its strategic building plan....

Which stocks are moving on Friday?

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Which stocks are gapping on Thursday?

Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

These stocks are moving in today's after hours session

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Which stocks are experiencing notable movement on Wednesday?

Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Wednesday's session: most active stocks

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active stocks in today's session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Get insights into the top gainers and losers of Wednesday's pre-market session.

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Let's have a look at the top gainers and losers in the middle of the day of today's session.

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Regina Graul, Ph.D., has been promoted to Chief Executive Officer, President, and member of the Board of Directors of Cyclerion....

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024

Cyclerion Therapeutics just reported results for the first quarter of 2024.

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

Cyclerion Therapeutics just reported results for the fourth quarter of 2023.

CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quart...

Cyclerion Appoints Regina Graul, Ph.D., as President

Cyclerion Appoints Regina Graul, Ph.D., as President

– Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep...

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

- Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreaking wireless devices for passive assessment of symptoms, behavior, and treatment responses in neurological and psychiatric disorders

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets

        – Asset Purchase Agreement Closed; Cyclerion Received Equity Ownership in Tisento and Upfront Cash Payment – – Tisento Developing Zagociguat in...

Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement

CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it...